Latest Market News

Pioneer Lithium advances uranium exploration with promising high-grade assays at Skull Creek, while pausing lithium activities amid market downturn. A recent $320,000 capital raise supports ongoing uranium projects in the US and Namibia.

Wellnex Life Limited reported a robust Q4 FY25 with a 22% sales increase and positive operational cash flow, underpinning its strategic growth initiatives backed by new debt funding.

Admiralty Resources NL reported a cash balance of $1.738 million at the end of June 2025, supported by financing facilities that provide nearly seven quarters of operational funding. The company’s latest cash flow report reveals ongoing investment in exploration alongside careful management of its loan facilities.

Admiralty Resources NL reports steady progress at its Mariposa Iron Ore Project in Chile, securing a major sales contract and advancing critical infrastructure during Q2 2025.

Pacific Lime and Cement Limited has made significant strides in Papua New Guinea, rebranding and advancing key projects while initiating commercial quicklime shipments to Western Australia. The company’s robust cash position and community agreements set the stage for upcoming construction milestones.

I Synergy Group Limited has strengthened its equity base through multiple capital raises and entered a strategic AI collaboration framework with NASDAQ-listed Treasure Global Inc., signaling a pivot towards advanced technology infrastructure.

Quantum Graphite Limited has made significant strides in developing its Eyre Peninsula Graphite Hub, progressing detailed planning with government stakeholders and attracting new financiers for its Uley 2 project. Exploration and purification testwork updates promise to refine its resource and product quality outlook.

Tryptamine Therapeutics has initiated the first-ever clinical trial using IV-infused psilocin to treat Binge Eating Disorder, with patient dosing set to begin shortly and results expected by year-end.

Adherium Limited reports a robust 30% increase in US remote patient monitoring users and closes a $4.5 million capital raise, positioning itself for accelerated growth under new leadership.

Health and Plant Protein Group Ltd (HPP) ended FY25 Q4 with a strong cash position following a significant IRS payment, while signaling plans for shareholder returns and confidential corporate opportunities.

Vectus Biosystems confirms safety of its lead fibrosis drug VB0004 from Phase Ia/Ib trials and advances licensing talks globally, including in China, while managing costs and funding challenges.

RooLife Group (ASX, RLG) reported $1 million revenue in Q4 FY2025, driven by its UK TikTok marketplace launch and a major solar product order from India, while divesting its digital marketing arm and cutting staff costs.